Search

A 34-year-old man presented with bloody urethral discharge, dysuria, cough and right testicular mass. He had a history of anterior urethral stricture and multiple urethral dilation procedures. Radical orchiectomy and urethral mass biopsy were performed. The pathologist reported both of specimens revealed embryonal carcinoma. Abdominal and chest CT scan showed multiple metastasis. chemotherapy was started with the Bleomycin, Etoposide, and Cisplatin (BEP) regimen and this cycle was repeated every 3 weeks up to four times. Unfortunately, this patient died of brain metastasis.

Background and aims Enhanced external counterpulsation (EECP) is a noninvasive treatment option which has been recently applied in patients with erectile dysfunction (ED). The aim of this study was to review the efficacy of EECP in patients suffering from ED. Methods PubMed, MEDLINE, Google Scholar, Tripdatabase, Scopus and Cochrane library databases were searched for articles with the following search terms: Enhanced external counterpulsation, erectile dysfunction. No restrictions with respect to study setting, date of publication or language were imposed. Results From an initial set of 208 records, four studies were selected after final review. Total number of 177 patients was included in these studies with the treatment duration with EECP ranging from 20 to 35 hours weekly. Peak systolic flow, quality of erection, International index of erectile function (IIEF) and overall satisfaction were all significantly increased after EECP treatment. Conclusion To the best of our knowledge, this is the first study reviewing the clinical effectiveness of EECP in patients with ED. According to the articles mentioned in this study, an enhancement in erectile function after EECP treatment courses has been observed in patients both with and without coronary artery disease without any significant adverse effects.